Report - GLAXOSMITHKLINE INNOVATIVE PIPELINE -  · Sir Andrew Witty (CEO): Welcome everybody to this R&D Investor Update from GSK here in New York. I would like to also say welcome to everybody

Please pass captcha verification before submit form